AIC468, a Novel Antisense Oligonucleotide in Clinical Development for the Treatment of BKV in Kidney Transplant Recipients: Evidence of Broad BKV Strain Coverage and a Low Probability of Pre‑Existing Drug Resistance

AIC468 - AiCuris

Angelica Lorenzo, n/a; Jurrien Prins, n/a; Eric Van der Veer, n/a; Peter Lischka, PhD (he/him/his)

Sep 6, 2026